Contralateral breast symmetrisation in unilateral DIEP flap breast reconstruction by Wade, Ryckie G. et al.
Accepted Manuscript
Contralateral breast symmetrisation in unilateral DIEP flap breast reconstruction
Ryckie G. Wade, MBBS MClinEd MRCS FHEA, Francesco Marongiu, MD, Elaine
Sassoon, AB FRCS(Plast), Richard Haywood, MBBS FRCS(Plast), Rozina Ali, BSc
MBBS MD FRCS(Plast), Mr. Andrea Figus, MD PhD FEBOPRAS, Consultant Plastic
and Reconstructive Surgeon, Clinical Senior Lecturer in Clinical Anatomy and Plastic
Surgery
PII: S1748-6815(16)30125-5
DOI: 10.1016/j.bjps.2016.06.009
Reference: PRAS 5025
To appear in: Journal of Plastic, Reconstructive & Aesthetic Surgery
Received Date: 16 February 2016
Revised Date: 27 April 2016
Accepted Date: 6 June 2016
Please cite this article as: Wade RG, Marongiu F, Sassoon E, Haywood R, Ali R, Figus A, Contralateral
breast symmetrisation in unilateral DIEP flap breast reconstruction, British Journal of Plastic Surgery
(2016), doi: 10.1016/j.bjps.2016.06.009.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
 
 
ACCEPTED MANUSCRIPT
Page 1 of 16 
 
Title 
Contralateral Breast Symmetrisation in Unilateral DIEP Flap Breast Reconstruction 
 
Running Head 
Contralateral Symmetrisation in Unilateral DIEP Flap Breast Reconstruction  
 
Authors 
Ryckie G Wade MBBS MClinEd MRCS FHEA 1, 2 
Francesco Marongiu MD 1 
Elaine Sassoon AB FRCS(Plast) 1 
Richard Haywood MBBS FRCS(Plast) 1 
Rozina Ali BSc MBBS MD FRCS(Plast) 1 
Andrea Figus MD PhD FEBOPRAS 1, 3 
 
Institutions 
1. Department of Plastic and Reconstructive Surgery, Norfolk and Norwich University Hospital 
NHS Foundation Trust, UK 
2. The School of Medicine, University of Leeds, Leeds, UK 
3. Faculty of Medicine and Health Sciences, Norwich Medical School, University of East 
Anglia, UK 
 
Corresponding Author 
Mr Andrea Figus MD PhD FEBOPRAS 
Consultant Plastic and Reconstructive Surgeon  
Clinical Senior Lecturer in Clinical Anatomy and Plastic Surgery 
Department of Plastic and Reconstructive Surgery 
Norfolk and Norwich University Hospital NHS Foundation Trust 
Norwich, Norfolk, NR4 7UY, UK. E-mail: andrea.figus@nnuh.nhs.uk 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
 
 
ACCEPTED MANUSCRIPT
Page 2 of 16 
 
 
Presentations 
1. The 63rd National Meeting of the Italian Society of Plastic, Reconstructive and Aesthetic 
Surgery, (SICPRE). Palermo, Italy. September 24-27th 2012. 
2. The Italian Society of Microsurgery (SIM) Symposium. Sassari, Italy. October 12th 2012. 
3. The Winter Meeting of the British Association of Plastic, Aesthetic and Reconstruction 
Surgeons, (BAPRAS). 19-21st June 2013; East Midlands Conference Centre, Nottingham, 
UK. 
4. The 25th Annual Meeting of the European Association of Plastic Surgeons, (EURAPS). 29-
31st May 2014; Lacco Ameno, Isle of Ischia, Italy. 
 
Acknowledgements 
We thank William JH Holmes for his constructive external review. 
 
 
Ethical approval 
Not required. 
 
Keywords 
DIEP; deep inferior epigastric artery perforator flap; breast reconstruction; symmetrisation; 
symmetrisation; contralateral; balancing; mastopexy; augmentation; mammoplasty; breast 
reduction; immediate; delayed; microvascular; free flap; complication; complications; adverse 
outcomes; failure; risk; revision. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
 
 
ACCEPTED MANUSCRIPT
Page 3 of 16 
 
Abstract 
Introduction: Women undergoing unilateral DIEP flap breast reconstruction may be offered a 
contralateral symmetrisation either at the time of reconstruction (simultaneous/immediate) or at a 
later stage (delayed). Simultaneous contralateral breast symmetrisation may be more beneficial to 
patients and healthcare institutions by avoiding staged surgery, although there is limited evidence 
on which to base practice. This deficit formed the rationale for our study. The primary outcome was 
the overall rate of revision surgery.  
Methods: Over a 6-year period, this prospective cohort study recorded the demographics, cancer 
treatments and operative outcomes of all consecutive unilateral DIEP flap breast reconstructions 
with or without contralateral symmetrising surgery. Patients were categorised into three groups: 1) 
simultaneous symmetrisation, 2) delayed symmetrisation, and 3) no symmetrisation for 
comparative analysis.  
Results: During the study period, 371 women underwent unilateral DIEP flap breast 
reconstruction; 194 (52.3%) were not symmetrised, 155 (41.8%) were simultaneously symmetrised 
and 22 (5.9%) underwent delayed symmetrisation. Symmetrising the contralateral breast at the 
same time as unilateral DIEP flap breast reconstruction increased the mean total operative time by 
28 minutes. There were no differences in the rates of peri-operative complications. There were 
significantly higher rates of all-cause revision surgery (OR 3.97 [1.58, 9.94], p=0.003) in women 
undergoing delayed symmetrisation, due to higher rates of revision lipomodelling, scar revision and 
revision contralateral symmetrisation.  
Conclusion: Simultaneous contralateral breast symmetrisation was associated with a lower risk of 
all-cause revision surgery. It is safe, beneficial and likely to be more cost-effective for women 
undergoing unilateral free DIEP flap breast reconstruction. 
 Abstract word count = 250 
Article wound count = 2690 
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Introduction 
 
Following mastectomy for breast cancer, autologous tissue breast reconstruction offers the 
greatest level of patient satisfaction1 and the deep inferior epigastric artery perforator (DIEP) flap is 
evolving as the ideal option for breast reconstruction2-5. To improve aesthetic outcomes after 
mastectomy, women undergoing unilateral breast reconstruction may be offered a contralateral 
balancing procedure including breast reduction, mastopexy or augmentation in order to attain 
symmetrical breast mounds6. This may be performed either at the time of reconstruction 
(immediate/simultaneous symmetrisation) or at a later stage (delayed symmetrisation) and the 
rising demand for symmetrising procedures are having an increasing impact on the length of 
waiting lists and breast surgeons’ workload7.  
 
Nowadays, patients and health care providers expect excellent outcomes with fewer risks and 
lower costs. Unilateral DIEP flap breast reconstruction is well known to be associated with a certain 
number of secondary procedures to improve outcomes. Revision surgery usually impacts patients’ 
lives and certainly adds demand on stretched health care resources. Therefore, the importance of 
achieving good outcomes and reducing the need for revision surgery has become an important 
target to be achieved. 
 
The potential advantages of immediate symmetrisation includes: a single operation and hospital 
admission with associated morbidity reductions and cost-savings for patients and health services 
alike5, 8-10, reduced patient distress due to breast asymmetry10, as well as the opportunity to sample 
contralateral breast tissue for occult malignancy11, 12. Conversely, some claim that a staged 
approach may allow better symmetry to be achieved because the procedure is planned to take 
place once the breast reconstruction is considered stable13-15. Overall, the ideal timing of 
contralateral breast symmetrisation with unilateral autologous tissue breast reconstruction remains 
controversial16. 
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To-date, the literature on unilateral DIEP flap breast reconstruction with contralateral breast 
symmetrisation is limited8-10, 13, 16-19 in terms of the potential advantages, patient-reported outcomes 
and rates of complications; the latter of which formed the rationale for this study. 
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Methods and Materials 
Between January 1st 2009 and December 31st 2014, an electronic database was prospectively 
completed for all consecutive patients undergoing DIEP flap breast reconstruction in a single 
centre, based on the design of a cohort study. This database was constantly updated and 
correlated with written and electronic patients’ notes to ensure accuracy and completeness of data. 
Patients were categorised as ‘no symmetrisation’, ‘immediate symmetrisation’ or ‘delayed 
symmetrisation’ for comparative analysis.  
 
Our primary outcome measure was the rate of all-cause revision surgery between groups. Our 
secondary outcomes measures included details of the operative technique (mastectomy weight, 
flap weight, reduction weight and operative time), peri-operative complications requiring a return to 
theatre and details of requisite revision breast or abdominal surgery. 
 
In our centre, all women undergoing mastectomy for breast cancer are offered reconstruction, with 
either autologous tissue or implants guided by patient preference and clinical indications20. Most of 
our patients choose a DIEP flap breast reconstruction. We offer contralateral breast 
symmetrisation either when patients request balancing or when unilateral DIEP flap breast 
reconstruction will predictably result in a size discrepancy. During the study period, all surgeons 
offered immediate and delayed balancing surgery with equipoise, in order to allow patients to make 
a personal decision about the timing of their possible symmetrisation. 
 
We perform unilateral DIEP flap breast reconstruction with two senior surgeons and two trainees. 
Whether undertaken at the time of reconstruction, or as a delayed procedure, we perform 
contralateral breast implant augmentation, reduction or mastopexy as required. We use the Wise 
pattern with supero-medial pedicle and inverted-T scar21, Hall-Findlay21 or Lejour22 vertical scar 
techniques in descending order of preference. All breast tissue removed from the contralateral 
breast is routinely sent for histology. When performing unilateral DIEP flap breast reconstruction 
and immediate contralateral symmetrisation we first reduce the contralateral breast; this better 
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enables the surgeon to harvest, tailor and inset the DIEP flap to match the reduced breast. We 
also offer simultaneous nipple reconstruction for women undergoing immediate reconstruction, 
based on patient’s preference. All venous anastomoses were end-to-end with a Synovis® GEM 
Microvascular Anastomotic COUPLER. Patients with a BMI >30 kg/m2 are counselled regarding 
the increased overall risk of complications and advised to first lose weight. Similarly, smokers are 
advised to stop for at least 4 weeks prior to surgery. 
 
Breast cup size was reported by patients and not measured by researchers. An immediate DIEP 
flap breast reconstruction was performed at the time of mastectomy, whilst a delayed DIEP flap 
breast reconstruction was undertaken after all cancer related adjuvant treatments were completed. 
Peri-operative complications were defined as events, which occurred within 30 post-operative days 
and required a return to theatre. We categorised a partial flap loss as necrosis of the flap, which 
required sharp debridement but not removal of the entire flap. Revision surgeries were defined as 
surgical procedures performed after the 30th post-operative day. Revision surgery in relation to 
symmetrisation procedures was undertaken in the context of patient dissatisfaction and at their 
request.  
 
Data was input to SPSS v22 (IBM). Continuous variables approximating a normal distribution 
(according to QQ-plots) are presented by means and standard deviations (SD) and compared with 
independent samples t-tests or one-way ANOVA with Šídák correction as appropriate. Skewed 
distributions and integer variables are summarised by medians with interquartile ranges (IQR) and 
compared with the Mann-Whitney U-test or Kruskal-Wallis test as appropriate. Categorical 
variables are presented as frequencies (with percentages) and compared with Chi Square test or 
Fisher’s exact test as appropriate. Odds ratios (OR) express the likelihood of adverse outcomes. 
Significance was set at 5%. Confidence intervals (CI) are generated to the 95% level.
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Results 
During the study period, 371 women underwent unilateral DIEP flap breast reconstruction and of 
these, 177 (47.7%) underwent contralateral breast symmetrisation. There were 155 (87.6%) 
immediate and 22 (12.4%) delayed balancing procedures.  
 
Table 1 shows that participants’ baseline characteristics were similar and that no given variable 
biased our decision regarding contralateral symmetrisation. There were no between-group 
differences in age of menarche or menopause, parity or breast feeding. As expected, women who 
required contralateral symmetrisation had a statistically higher BMI than women who did not. 
Similarly, women who required symmetrisation had larger reported breast cup sizes (modal cup 
size: no symmetrisation group B cup, immediate symmetrisation D cup, delayed symmetrisation D 
cup, p<0.001). The timing of DIEP flap breast reconstruction was not associated with the rate of 
immediate or delayed contralateral symmetrisation. 
 
We used a Wise pattern with supero-medial pedicle in 138 patients (78.0%), a superior pedicle in 
10 patients (5.7%) and an inferior pedicle in 3 patients (1.7%). We performed 17 Hall-Findlay 
(9.6%) and 9 Lejour (5.0%) vertical scar technique reduction/mastopexy procedures. No 
contralateral augmentations were performed in this consecutive series.  
  
Table 2 shows that women undergoing simultaneous symmetrisation had a greater median 
mastectomy weight and required an additional mean 28 minutes of operating time (95% CI 7, 47 
minutes). The total operating time range (in hours:minutes) for women who were not 
simultaneously symmetrised (ie. our time to perform a standard unilateral DIEP flap breast 
reconstruction) was 3:00 to 10:00, with a mean of 5:51. This was compared to women having an 
additional simultaneous symmetrisation procedure whose operating times ranged from 3:22 to 
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12:12, with a mean of 6:19. The median breast reduction weight for the women undergoing 
simultaneous symmetrisation was no different to women who later underwent (delayed) 
contralateral breast reduction (306 vs. 289 grams, p=0.442).  
 
Performing an immediate contralateral breast symmetrisation did not increase the pooled risk of 
peri-operative complications requiring a return to theatre (Table 3). Conversely, we found that 
delaying the symmetrisation substantially increased the risk of revision surgery on the breasts and 
abdomen (Table 4). 
  
The SIEV was absent in 13 women (3.5%), preserved but not used in 322 patients (86.8%) and 
used to augment the venous drainage of 36 (9.7%) DIEP flaps at the time of reconstruction. The 
internal thoracic vessels (ITV) were the recipients for all flaps except one which was anastomosed 
to the TD vessels as the ITVs were damaged by radiotherapy. There were no between-group 
differences for COUPLER™ size, number of perforators per flap, location of the perforators (medial 
vs. lateral) or the orientation of the arterial anastomoses (end-to-end or end-to-side). Twenty-one 
women (5.7%) required a bipedicled unilateral DIEP flap breast reconstruction. Of these, 6 had 
immediate symmetrisation and 2 underwent delayed symmetrisation. Although these figures are 
limited, they may suggest that the need for contralateral surgery in unilateral bipedicled DIEP 
reconstruction is reduced, as may be expected. 
 
No patient required a peri-operative blood transfusion. One patient undergoing a delayed unilateral 
DIEP flap breast reconstruction with immediate contralateral Symmetrisation developed cellulitis of 
the abdominal wound which required intravenous antibiotics only. There were no occult 
malignancies found in the contralateral breast tissue in our series. 
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Discussion 
Few authors have described the outcomes of immediate contralateral breast symmetrisation in 
association with unilateral free flap breast reconstruction8-10, 13, 16-19. Despite delayed 
symmetrisation being the most popular approach, the limited data on contralateral symmetrisation 
with unilateral DIEP flap breast reconstruction is largely in favour of simultaneous surgery8-10, 16-18. 
Although we recognise that the current literature is of varying methodological quality, our findings 
do support the evolving notion that immediate contralateral balancing surgery is safe, beneficial 
and potentially more cost-effective5.  
 
The most important finding of our study (and our primary outcome) was the need for all-cause 
revision surgery; we found a significantly higher rate of revision surgery in women undergoing 
delayed contralateral symmetrisation. The popular belief is that the contralateral breast should not 
be symmetrised at the time of reconstruction as the flap should be allowed time to ‘settle’ before 
the surgeon attempts to match the native breast. However, we have shown that the incidence of 
all-cause revision surgery was nearly four times higher in women opting for a delayed 
symmetrisation (OR 3.97) than those balanced simultaneously (Table 4). We observed 
independently higher risks of revision breast surgery and abdominal surgery in the delayed 
symmetrisation group. The higher risks of revision breast surgery in the delayed group was due to 
higher rates of lipomodelling and revision reduction/mastopexy procedures. This is certainly 
multifactorial and difficult to explain with the available data. The suggestion that symmetry may be 
better improved with a simultaneous contralateral breast reduction needs more robust evidence. 
Unexpectedly, we found that the rates of abdominal scar revisions were also significantly higher in 
the delayed symmetrisation group but root-cause analysis suggests that the majority of abdominal 
revision surgeries were simply opportunistic, for example, women requested revision breast 
surgery and so the surgeon used the opportunity to revise the abdominal scar. On the basis of this 
finding, we may state that women who have their mastectomy, reconstruction and symmetrisation 
as one single operation may be happier with their outcome9 and so, less likely to consult the 
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surgeon for revision surgery (whether this is related to the quality of the outcome, patient 
satisfaction or otherwise is still unknown). In support of this hypothesis, Yip et al (2015) showed 
that in the context of reconstruction and contralateral symmetrisation, breast volume symmetry was 
not related to satisfaction but most influenced by the pre-operative care as part of the 
reconstructive ‘process’23. Further, Huang8, 9, Inbal10 and Laporta19 reported better or comparable 
satisfaction and aesthetic outcomes with immediate symmetrisation. However, in absence of a 
patient reported outcomes, we can only speculate on these matters and so share some example 
cases in Figures 1-5. None-the-less, in the current economic health climate, even if we are unable 
to fully explain the differences in the number of revision surgery between women undergoing 
immediate and delayed symmetrisation, we do add to the growing evidence base which suggests 
that delaying symmetrisation does not appear to be in the best interests of patients. We believe 
that a delayed approach involves more surgeries which may damage patients’ psychosocial 
wellbeing, affect work and life commitments; increase clinic demand, theatre time, hospital bed 
occupancy, the length of surgical waiting lists and follow-up appointments.   
 
Nowadays, patients and health care providers have increasing expectations for excellence in 
aesthetic and psychosocial outcomes from breast reconstruction after mastectomy and this 
includes breast symmetry. Public expectations come alongside bureaucratic pressures to reduce 
the cost and morbidity of surgery for such patients. Whilst unilateral DIEP flap breast 
reconstruction is the gold standard1, 4, many women do need revision surgery or secondary 
procedures which are aimed at improving the final result. Currently, nearly 50% of our breast 
reconstruction patients opt for contralateral balancing surgery16 and so there is a large scope for 
additional surgery to be factored into a busy breast reconstruction service. Our results show that 
immediate breast symmetrisation can be safely undertaken for women with a wide range of breast 
sizes, including those with a substantial difference between the contralateral breast and the 
amount of available lower abdominal tissue. In fact, our findings suggest that immediate 
symmetrisation was performed in patients with a large discrepancy between mastectomy and DIEP 
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flap weights (approximately 400 grams). Moreover, there was no significant difference in breast 
reduction weights between those women who underwent simultaneous or delayed contralateral 
breast reduction. Although the decision to perform contralateral breast symmetrisation involves 
both the surgeon and patient, surgeons can strongly influence patients’ decisions so equipoise is 
important24. Whilst our patients do seem to prefer the option of breast reconstruction and 
contralateral symmetrisation in a single operation, we cannot exclude the possibility that we biased 
their decision or that our population is confounded. None-the-less, the recent literature supports 
simultaneous contralateral symmetrisation and in the absence of results from randomized trials, 
this is the consensus of the best evidence to-date8-10, 16-19. 
 
Performing a contralateral breast symmetrisation can increase the average operative time. In our 
series, this balancing procedure added a mean of 28 minutes to the surgery (with a 95% 
confidence interval of 7 to 47 minutes). As our DIEP flap breast reconstructions are performed with 
two senior surgeons and their trainees, this does permit surgery on both the breast(s) and 
abdomen simultaneously, which may help to explain why the contralateral procedure added such a 
small amount of extra time. We did not measure the operative time of delayed contralateral 
symmetrisation, which was an oversight, but secondary procedures in our hands usually take 
longer than 28 minutes and clearly the overall total anaesthetic time will be substantially greater. 
Also, it would appear that immediate symmetrisation does not increase the risk of peri-operative 
complications, which again challenges popular belief and is an important finding. Whilst our 
approach may not be appropriate for the solo reconstructive breast surgeon, we have shown that 
simultaneous symmetrisation can be safely performed, with potential reductions in morbidity and 
costs afforded by avoiding a staged procedure. 
 
When interpreting our findings, limitations must be considered. An oversight in our data collection 
meant that some variables lacked details, which may have been useful eg. the time interval 
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between DIEP flap breast reconstruction and delayed contralateral symmetrisation or revision 
surgeries (we usually wait at least 6 months) and the operative time for the delayed symmetrisation 
cases. We also cannot be certain whether patients sought revision surgery at other Institutions or 
privately. We did not measure patient reported outcomes, as this was not our aim and therefore the 
interpretation of results and application to clinical practice needs more evidence. We undertook 
multiple statistical comparisons and so the chance of Type 1 error(s) is very high. Given the 
requisite study design and sample size, some outcomes are likely to be biased and potentially 
confounded. The example is the higher rate of abdominal donor site revisions in the delayed 
symmetrised group. Theoretically, the donor site revision rate should have been the same because 
the same procedure was undertaken (raising a DIEP flap for unilateral reconstruction) in both 
groups, so whether this represents confounding by unmeasured variable(s)s or simply 
opportunistic scar revision, during a second stage procedure, is unknown. 
 
Our findings challenge a popular assumption and have shown immediate contralateral breast 
symmetrisation with unilateral free DIEP flap breast reconstruction to be associated with a lower 
risk of all-cause revision surgery. Simultaneous contralateral breast symmetrisation can be safe, 
beneficial and cost-effective with no significant additional risks of complications for women 
undergoing unilateral free DIEP flap breast reconstruction. Certainly, more research needs to be 
conducted on this topic and future work should aim to prospectively assess both surgical outcomes 
(ie. complications as we have done) alongside patient-reported outcomes (ie. satisfaction) in much 
larger cohorts of women, ideally as multicentred randomised trials. 
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Figure Legends 
Figure 1. a-c) Pre-operative photographs of a 67 year old woman with 38-D bra-cup size and a 
right invasive breast carcinoma. d-f) 12-months post right mastectomy (692g) and immediate DIEP 
flap breast reconstruction (515g) with immediate contralateral breast reduction (184g).  
 
Figure 2. a-c) Pre-operative photographs of a 56 year old woman with 40-E bra-cup size and a left 
sided invasive breast carcinoma. d-f) 36-months post left mastectomy (1323g) and immediate 
DIEP flap breast reconstruction (872g) with immediate contralateral breast reduction (528g).  
 
Figure 3. a-c) Pre-operative photographs of a 57 year old woman with 40-DD bra-cup size and a 
left sided invasive breast carcinoma. d-f) 8-months post left mastectomy (1083g) and immediate 
DIEP flap breast reconstruction (940g). g-i) 16-months post delayed contralateral breast reduction 
(332g).   
 
Figure 4. a-c) Pre-operative photographs of a 44 year old woman with 38-D bra-cup size following 
right mastectomy (826g) and axillary lymph node clearance for breast cancer. d-f) 12-months post 
right delayed DIEP flap breast reconstruction (582g) with immediate contralateral breast reduction 
(231g).  
 
Figure 5. a-c) Pre-operative photographs of a 57 year old woman with 36-C bra-cup size following 
left mastectomy (436g) and axillary lymph node clearance for invasive breast carcinoma. d-f) 6-
months post left delayed DIEP flap breast reconstruction (414g). g-i) 18-months post delayed 
contralateral peri-areolar mastopexy. 
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Table 1. Baseline 
Characteristics 
No 
Symmetrisation 
(N=194) 
Simultaneous 
Symmetrisation 
(N=155) 
Delayed 
Symmetrisation 
(N=22) 
p-value 
Age (SD) 56.4 (9.08) 57.3 (9.35) 54.5 (10.4) 0.372 
BMI (SD) 26.0 (2.70) 27.6 (3.13) 26.3 (3.76) 0.006 
Smoking history (%) 35 (18.0) 21 (13.5) 5 (22.7) 0.444 
Lower abdominal scars (%) 50 (25.8) 41 (26.5) 6 (27.3) 0.962 
Oncological 
treatment (%) 
Neo-adjuvant 
chemotherapy 
12 (6.19) 20 (12.9) 1 (4.55) 0.062 
Adjuvant 
chemotherapy 
107 (55.2) 94 (60.7) 10 (45.5) 0.235 
Adjuvant 
radiotherapy 
95 (49.0) 83 (53.5) 10 (45.5) 0.516 
Adjuvant 
hormone 
therapy 
111 (57.2) 106 (68.4) 16 (72.7) 0.044 
Breast 
reconstruction 
timing (%) 
Immediate 73 (37.6) 42 (27.1) 5 (22.7) 
0.070 
Delayed 121 (62.4) 113 (72.9) 17 (77.3) 
 
Table 1. Baseline characteristics for all patients undergoing unilateral DIEP flap breast reconstruction 
compared with one-way ANOVA and Šídák correction.
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Table 2. Operative Variables for 
Women Undergoing Unilateral 
DIEP Flap Breast Reconstruction 
Without 
Simultaneous 
Symmetrisation 
(N=216) 
With 
Simultaneous 
Symmetrisation 
(N=155) 
p-value 
Mean Total Operative Time In 
hours:mins (SD) 5:51 (1:22) 6:19 (1:30) 0.006 
Median ischaemia time in minutes per 
DIEP flap (IQR) 32.0 (17.0) 30.0 (15.0) 0.309 
Median mastectomy weight in grams 
per breast (IQR) 568 (290) 862 (491) <0.001 
Mean DIEP flap weight in grams per 
flap (SD) 625 (200) 646 (174) 0.318 
 
Table 2. Operative variables for women undergoing DIEP flap breast reconstruction, grouped according to 
whether they had simultaneous symmetrisation or not.
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Table 3. Outcomes for Women 
Undergoing Unilateral DIEP flap 
Breast Reconstruction 
Without 
Simultaneous 
Symmetrisation 
(N=216) 
With 
Simultaneous 
Symmetrisation 
(N=155) 
p-value OR 95% CI 
Any post-operative complication 
requiring re-operation (%) 28 (13.0) 14 (9.03) 0.251 0.67 0.34, 1.31 
Peri-operative 
complications 
requiring re-
operation (%) 
Haematoma of the 
DIEP flap 7 (3.23) 6 (3.87) 0.718 1.20 0.39, 3.63 
Haematoma of the 
abdominal donor site 0 (0) 2 (1.29) 0.512 - - 
Infected seroma of 
symmetrized breast 2 (0.93) 0 (0) 0.512 - - 
Debridement of 
umbilical stalk necrosis 2 (0.93) 0 (0) 0.512 - - 
Debridement of 
mastectomy skin 
envelope necrosis and 
skin grafting 
2 (0.93) 0 (0) 0.512 - - 
Venous congestion of 
the DIEP flap  7 (3.23) 4 (2.58) 0.768 0.79 0.23, 2.75 
Ischaemia of the DIEP 
flap 4 (1.85) 2 (1.29) 1.000 0.69 0.13, 3.83 
Partial DIEP flap loss 6 (2.78) 5 (3.22) 1.000 1.17 0.35, 3.89 
Total DIEP flap loss 1 (0.46) 2 (1.29) 0.574 2.81 0.253, 31.3 
Median Days in Hospital (IQR) 6 (1) 6 (1) 0.305 - - 
 
Table 3. Peri-operative outcomes for women undergoing DIEP flap breast reconstruction, grouped according 
to whether they had simultaneous symmetrisation or not (ie. for this analysis we have group women who 
were never symmetrized with those who were balanced at a secondary surgery as they are comparable at 
this stage). 
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Table 4. Revision Surgery 
Immediate 
Symmetrisation 
(N=155) 
Delayed 
Symmetrisation 
(N=22) 
p-value OR 95% CI 
Any Revision Surgery (%) 36 (23.2) 12 (54.5) 0.003 3.97 1.58, 9.94 
Cumulative Rate of Revision Breast 
Surgery (%) 30 (19.4) 11 (50.0) 0.003 4.17 1.65, 10.5 
Revision 
breast 
surgery (%) 
Any lipomodelling 15 (9.68) 7 (31.8) 0.007 4.57 1.59, 13.1 
DIEP flap remodelling 
or advancement 7 (4.51) 1 (4.54) 1.000 1.00 0.12, 9.00 
Excision of fat necrosis 2 (1.29) 1 (4.54) 0.330 3.64 0.32, 42.0 
Any scar revision 10 (6.45) 2 (9.10) 0.647 1.45 2.96, 7.10 
Revision NAC 
reconstruction 2 (1.29) 0 (0) 1.000 - - 
Revision native breast 
reduction or 
mastopexy 
6 (3.87) 4 (18.2) 0.023 5.52 1.42, 21.4 
Cumulative rate of revision abdominal 
surgery (%) 10 (6.45) 9 (40.9) <0.001 10.0 3.46, 29.1 
Revision 
abdominal 
surgery (%) 
Debridement and 
delayed closure after 
infected dehiscence 
2 (1.29) 0 (0) 1.000 - - 
Repair of abdominal 
wall hernia or bulge  2 (1.29) 2 (9.10) 0.076 7.65 1.02, 57.4 
Scar revision 6 (3.87) 7 (31.8) 0.002 7.92 2.37, 26.5 
 
Table 4. Revision surgeries on the breast and abdomen for patients who underwent contralateral breast 
symmetrisation following unilateral DIEP flap breast reconstruction 
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